CNS Study of Patients Switching From Tacrolimus to Envarsus
Status:
Active, not recruiting
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
This is a pilot study documenting the neurotoxic side effects including tremors in patients
with a stable graft who are receiving Tacrolimus following kidney transplantation. A
standardized questionnaire will be used to document these symptoms.